<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-97966</identifier>
<setSpec>0212-6567</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevalence of multiple medication and cardiovascular risk in patients over 65 years</dc:title>
<dc:description xml:lang="en">Objetive: To describe the prevalence of multiple medication in patients over 65 years. Design: Cross-sectional study. Setting: Sevilla and Jerez-Costa North-West Primary Health Care Districts. Participants: Patients older than 65 years randomly chosen from district databases. Patients in nursing homes, with major mental disease, or end-of- life situations were excluded. Main measurements: Multiple medication was defined as a prescription of five or more drugs during the last six months. We assessed the medication used by clinical health records audit. Other characteristics were studied by interviewing a subsample of patients. Results: A total of 2,919 clinical health records from 14 centres were reviewed. The prevalence of multiple medication was 49.6% (95% CI: 47.7-51.4) with a range from 33% (95% CI: 26.8-39.3) to 82% (95% CI: 74,3-89,7) between centres. The large majority of patients (90.2% [95% CI: 88.7-91.8]) of patients showed criteria to be included in Cardiovascular Risk Health Care Process. Interviewed patients confirmed taking an average of 8.7 drugs (95% CI: 8.4-9.0). Among them, 83.2% (95% CI: 78.9-87.4) were high cardiovascular risk patients. Conclusions: Prevalence of multiple medication in patients over 65 years is about 50% with wide variations between centres. The number of drugs per patient ratio was close to eight. A large majority of them were high risk cardiovascular patients(AU)</dc:description>
<dc:creator>López Rubio, Soledad</dc:creator>
<dc:creator>Palma Morgado, Daniel</dc:creator>
<dc:creator>Molina López, Teresa</dc:creator>
<dc:creator>Caraballo Camacho, María de la O</dc:creator>
<dc:creator>Morales Serna, Juan Carlos</dc:creator>
<dc:creator>Domínguez Camacho, Juan Carlos</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Estudiar la prevalencia de polimedicación en mayores de 65 años. Diseño: Estudio descriptivo transversal. Emplazamiento: Distritos sanitarios de atención primaria Sevilla y Jerez-Costa Noroeste. Participantes: Población mayor de 65 años, seleccionada por un procedimiento aleatorio estratificando por centros. Se excluyeron pacientes institucionalizados, con trastornos de salud mental mayores y enfermedad terminal. Mediciones principales: Se definió polimedicación como el consumo de 5 o más fármacos de forma continuada durante los últimos 6 meses, basado en el registro en historia clínica. Se exploraron otras características de los pacientes mediante entrevista a una submuestra seleccionada aleatoriamente. Resultados: Se evaluaron las historias clínicas de 2.919 pacientes procedentes de 14 centros de salud. La prevalencia encontrada fue de 49,6% (IC 95%: 47,7-51,4), con un rango entre centros de un 33% (IC 95%: 26,8-39,3) a un 82% (IC 95%: 74,3-89,7). El 90,2% (IC 95%: 88,7-91,8) tenía criterios de entrada al Proceso Asistencial Integrado Riesgo Vascular. La entrevista confirmó un consumo promedio de 8,7 medicamentos (IC 95%: 8,4-9,0). Un 83,2% (IC 95%: 78,9-87,4) eran pacientes en riesgo vascular alto. Conclusiones: La prevalencia de polimedicación en mayores de 65 años es cercana al 50%, con amplia variabilidad entre centros. El consumo promedio de medicamentos por paciente es de 8 y la gran mayoría son pacientes en riesgo vascular alto(AU)</dc:description>
<dc:source>Aten Primaria;44(4): 216-222, abr. 2012.</dc:source>
<dc:identifier>ibc-97966</dc:identifier>
<dc:title xml:lang="es">Prevalencia de polimedicación y riesgo vascular en la población mayor de 65 años</dc:title>
<dc:subject>^d28563^s22067</dc:subject>
<dc:subject>^d4422^s22066</dc:subject>
<dc:subject>^d8676^s22048</dc:subject>
<dc:subject>^d4422^s22041</dc:subject>
<dc:subject>^d3709^s22045</dc:subject>
<dc:subject>^d4400</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d4422^s22048</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d52955^s37748</dc:subject>
<dc:subject>^d52955^s22074</dc:subject>
<dc:subject>^d28596^s22045</dc:subject>
<dc:subject>^d52955^s22083</dc:subject>
<dc:subject>^d4422^s37748</dc:subject>
<dc:subject>^d28596^s22074</dc:subject>
<dc:subject>^d52955^s22066</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d52955^s22048</dc:subject>
<dc:subject>^d28563^s22080</dc:subject>
<dc:subject>^d10353</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>201204</dc:date>
</metadata>
</record>
</ibecs-document>
